@markhughes
Yes they are, do your research please, MSB provide Rem-L under a different name to JCR Japan.
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-503
-
- There are more pages in this discussion • 345 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.056B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1379 | 98.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 88.0¢ | 2885 | 1 |
View Market Depth
| Last trade - 10.02am 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable